JP3219274B2 - 新しいヒト組み換えガンマ−インターフェロン - Google Patents

新しいヒト組み換えガンマ−インターフェロン

Info

Publication number
JP3219274B2
JP3219274B2 JP50025492A JP50025492A JP3219274B2 JP 3219274 B2 JP3219274 B2 JP 3219274B2 JP 50025492 A JP50025492 A JP 50025492A JP 50025492 A JP50025492 A JP 50025492A JP 3219274 B2 JP3219274 B2 JP 3219274B2
Authority
JP
Japan
Prior art keywords
interferon
gamma
polypeptide
amino acid
restriction endonuclease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP50025492A
Other languages
English (en)
Japanese (ja)
Other versions
JPH06502992A (ja
Inventor
スロドウスキ，オットー
ベーム，ヨアヒム
オットー，ベルント
Original Assignee
フラウンホーファー―ゲゼルシャフト ツア フェルデルング デア アンゲバンテン フォルシュング エー．ファウ．
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by フラウンホーファー―ゲゼルシャフト ツア フェルデルング デア アンゲバンテン フォルシュング エー．ファウ． filed Critical フラウンホーファー―ゲゼルシャフト ツア フェルデルング デア アンゲバンテン フォルシュング エー．ファウ．
Publication of JPH06502992A publication Critical patent/JPH06502992A/ja
Application granted granted Critical
Publication of JP3219274B2 publication Critical patent/JP3219274B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/57—IFN-gamma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Urology & Nephrology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Rheumatology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pain & Pain Management (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
JP50025492A 1990-11-19 1991-11-14 新しいヒト組み換えガンマ−インターフェロン Expired - Fee Related JP3219274B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE4036856A DE4036856C1 (enExample) 1990-11-19 1990-11-19
DE4036856.4 1990-11-19
PCT/DE1991/000912 WO1992008737A1 (de) 1990-11-19 1991-11-14 Neues menschliches, rekombinantes interferon gamma

Publications (2)

Publication Number Publication Date
JPH06502992A JPH06502992A (ja) 1994-04-07
JP3219274B2 true JP3219274B2 (ja) 2001-10-15

Family

ID=6418557

Family Applications (1)

Application Number Title Priority Date Filing Date
JP50025492A Expired - Fee Related JP3219274B2 (ja) 1990-11-19 1991-11-14 新しいヒト組み換えガンマ−インターフェロン

Country Status (9)

Country Link
EP (1) EP0652903B1 (enExample)
JP (1) JP3219274B2 (enExample)
AT (1) ATE163651T1 (enExample)
AU (1) AU9026691A (enExample)
CA (1) CA2096532C (enExample)
DE (2) DE4036856C1 (enExample)
DK (1) DK0652903T3 (enExample)
ES (1) ES2114555T3 (enExample)
WO (1) WO1992008737A1 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19535853C2 (de) * 1995-09-18 1999-04-01 Fraunhofer Ges Forschung Varianten des rekombinanten humanen Interferon-gamma, Verfahren zu ihrer Herstellung und ihre Verwendung
DE19604583C2 (de) * 1996-02-08 1999-11-18 Fraunhofer Ges Forschung Verfahren zur Synthese von löslichen, rekombinanten Proteinen aus Bakterienzellen
JP2003513681A (ja) 1999-11-12 2003-04-15 マキシゲン・ホールディングス・リミテッド インターフェロンガンマ・コンジュゲート
US7230081B1 (en) 1999-11-12 2007-06-12 Maxygen Holdings, Ltd. Interferon gamma conjugates
US7038015B2 (en) 2001-04-06 2006-05-02 Maxygen Holdings, Ltd. Interferon gamma polypeptide variants
US6958388B2 (en) 2001-04-06 2005-10-25 Maxygen, Aps Interferon gamma polypeptide variants
PL366705A1 (en) * 2001-04-06 2005-02-07 Maxygen Holdings Ltd. Interferon gamma polypeptide variants
WO2004005341A2 (en) 2002-07-03 2004-01-15 Maxygen Holdings Ltd. Full-length interferon gamma polypeptide variants
JP7611820B2 (ja) 2018-10-11 2025-01-10 インヒブルクス バイオサイエンシズ インコーポレイテッド Ｄｌｌ３シングルドメイン抗体およびその治療用組成物
AU2019356573B2 (en) 2018-10-11 2025-12-18 Inhibrx Biosciences, Inc. PD-1 single domain antibodies and therapeutic compositions thereof
CN113166261A (zh) 2018-10-11 2021-07-23 印希比股份有限公司 B7h3单域抗体及其治疗性组合物
US12590169B2 (en) 2018-10-11 2026-03-31 Inhibrx Biosciences, Inc. 5T4 single domain antibodies and therapeutic compositions thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4855238A (en) * 1983-12-16 1989-08-08 Genentech, Inc. Recombinant gamma interferons having enhanced stability and methods therefor
IL75302A0 (en) * 1984-06-06 1985-09-29 Takeda Chemical Industries Ltd Novel polypeptide and production thereof
JPS6124599A (ja) * 1984-07-11 1986-02-03 Kyowa Hakko Kogyo Co Ltd 新規ヒトインタ−フエロン−ｒポリペプチド誘導体
GB8619725D0 (en) * 1986-08-13 1986-09-24 Hoffmann La Roche Homogenous interferon fragments
DE3730331A1 (de) * 1987-09-10 1989-03-30 Basf Ag Neue polypeptide, verfahren zur herstellung, die vektoren dafuer und arzneimittel daraus

Also Published As

Publication number Publication date
WO1992008737A1 (de) 1992-05-29
ATE163651T1 (de) 1998-03-15
DE4036856C1 (enExample) 1992-05-27
CA2096532A1 (en) 1992-05-20
EP0652903A1 (de) 1995-05-17
AU9026691A (en) 1992-06-11
EP0652903B1 (de) 1998-03-04
JPH06502992A (ja) 1994-04-07
CA2096532C (en) 2002-12-31
DK0652903T3 (da) 1998-03-30
DE59108947D1 (de) 1998-04-09
ES2114555T3 (es) 1998-06-01

Similar Documents

Publication Publication Date Title
US8557768B1 (en) Human nerve growth factor by recombinant technology
EP0043980B1 (en) Mature human leukocyte interferon a, process for its microbial preparation, intermediates therefor and compositions containing it.
EP0121338B1 (en) Biosynthetically produced human nerve growth factor, process for producing it, compositions containing it, dna sequence encoding it, vectors containing the sequence and host cells transformed thereby
Gray et al. Expression of human immune interferon cDNA in E. coli and monkey cells
JP2515308B2 (ja) ヒト免疫インタ−フエロン
AU594301B2 (en) Preparation of human igf and egf via recombnant dna technology
CA1341569C (en) Microbial production of human fibroblast interferon
US4414150A (en) Hybrid human leukocyte interferons
US5605688A (en) Recombinant dog and horse type I interferons
US6482613B1 (en) Microbial production of mature human leukocyte interferons
CA2232264C (en) Variants of human recombinant interferon-.gamma. (rhu-ifn-.gamma.) with increased thermal stability
EP0042246A2 (en) Plasmid
JPH07188294A (ja) 新規なポリペプチド、その製造方法、そのポリペプチドをコードするｄｎａ、そのｄｎａからなるベクター、そのベクターで形質転換された宿主細胞、そのポリペプチドの抗体、およびそのポリペプチドまたは抗体を含有する薬学的組成物
JPH06100593A (ja) 自然産生ｇ−ｃｓｆの誘導体及びその製造方法、及び、自然産生ｇ−ｃｓｆ誘導体のアミノ酸配列をエンコードするｄｎａ塩基配列
JPH09103295A (ja) 形質転換酵母によるヒルジンの発現及び抗凝血剤組成物
JPH04504064A (ja) 新規血小板由来成長因子ｂ鎖類似体及びその均質製造方法
CN101547935A (zh) 干扰素α突变体及其聚乙二醇衍生物
JPH0745516B2 (ja) ヒトγ―インターフェロン活性を有するポリペプチドおよびその製造法
CA2096532C (en) New human recombinant gamma-interferon
JPH06181771A (ja) 新規なヒトｉ型インターフェロン
EP0306870A2 (de) Gamma-Interferon-Derivate, Herstellungsverfahren, Vektoren dafür und Arzneimittel daraus
EP0263206B1 (en) Enhanced bioactivity of mammalian somatotropin through selective deamidation
JPS6196998A (ja) ヒトアポリポプロテインａ−ｉ様蛋白の産生方法
JPS62246522A (ja) インタ−ロイキン１を有効成分とする感染症予防・治療剤
JPS60222500A (ja) 新規ハイブリツドインタ−フエロン

Legal Events

Date Code Title Description
R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20080810

Year of fee payment: 7

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20080810

Year of fee payment: 7

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090810

Year of fee payment: 8

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100810

Year of fee payment: 9

LAPS Cancellation because of no payment of annual fees